Intraperitoneal Chemotherapy Alone or in Combination With Bevacizumab for Ovarian Cancer With Peritoneal Adhesion

NCT03095001 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Peritoneal Adhesion

Interventions

DRUG: Bevacizumab
DRUG: Carboplatin
DRUG: paclitaxel

Sponsor

Chinese PLA General Hospital